Method and apparatus for treatment of neurogenic diabetes mellitus, and other conditions
AssigneeNone recorded
InventorPeter J. Jannetta
Life of this patent
Estimating the term…
Loading patent…
AssigneeNone recorded
InventorPeter J. Jannetta
Estimating the term…
A method and implants provide for relieving pressure from a region of the brainstem within the cranium of a subject with a neuroendocrine servomechanism. The pressure results from the compression of the region by a blood vessel. The method includes gaining access to the region using a first surgical technique; exposing the region according to a second surgical technique; lifting the blood vessel from the region according to a third surgical technique, thereby providing the pressure relief; and inserting a neurovascular bridge implant between the blood vessel and the region to maintain the pressure relief. The neuroendocrine servomechanism is responsive to the pressure relief on the region, causing amelioration of a disease. One neuroendocrine servomechanism can include the pancreas of the subject, and the pressure relief ameliorates non-insulin-dependent diabetes mellitus. The neurovascular bridge implant can be a preconfigured shredded plastic implant, made of polytetrafluoroethylene, or a preconfigured thermoplastic implant, made of a polyurethane-based material having a glass-transition temperature of between 20.degree. C. to 60.degree. C. and a transition band of about 8.degree. C.
A neurovascular bridge implant for relieving pressure between a blood vessel and a preselected region of the brainstem, the pressure resulting from the compression of the region by said blood vessel, the implant comprising one of a preconfigured shredded plastic implant and a preconfigured thermoplastic implant, said implant being shaped and sized to fit between said blood vessel and said predetermined region of the brainstem and being positioned between said blood vessel and said predetermined region of the brainstem, wherein the implant relieves the pressure between the blood vessel and the preselected region and maintains the pressure relief, the pressure relief ameliorating a disorder of the normal neuroendocrine servomechanism.
A neurovascular bridge implant for relieving pressure between a blood vessel and a preselected region of the brainstem, the pressure resulting from the compression of the region by said blood vessel, the implant comprising one of a preconfigured shredded plastic implant and a preconfigured thermoplastic implant, said implant being shaped and sized to fit between said blood vessel and said predetermined region of the brainstem and being positioned between said blood vessel and said predetermined region of the brainstem wherein the implant relieves the pressure between the blood vessel and the preselected region and maintains the pressure relief, the pressure relief ameliorating non-insulin-dependent diabetes mellitus.
A neurovascular implant for relieving pressure between a blood vessel and a preselected region of the brainstem, the pressure resulting from the compression of said region by said blood vessel, the pressure relief ameliorating a disorder of the normal neuroendocrine servomechanism, said implant comprising:
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Term ended 5 Oct 2015 (estimated)
USPTO file history isn’t available for this patent, so only indexed dates are shown.
1. Field of the Invention
This invention relates to the field of neurosurgery, in particularly, a neurosurgical treatment for neurogenic disorders and, more specifically, to a neurosurgical method for the treatment of neurogenic conditions, including diabetes mellitus, by microvascular decompression of the medulla oblongata and viscera-related cranial nerves.
2. Background Art
FIG. 1 is a basilar view of the brain illustrating the blood vessels and cranial nerves at the base of the brain.
FIG. 2 is a top view of a cross-section of a normal medulla oblongata at the root entry zone of the cranial nerve X.
FIG. 3 is a top view of the cross-section in FIG. 2 showing vascular compression of the right ventrolateral medulla.
The invention herein provides a method and devices for treating a neuroendocrine disease that is caused or exacerbated by vascular compression of the brainstem and the associated cranial nerves. By initiating and maintaining decompression of the relevant neural tissue, the diminished neuroendocrine servomechanisms can be encouraged to regain sufficient functioning as to effect the elimination or long term amelioration of the target neuroendocrine disease, e.g., NIDDM.
In one embodiment of the present invention, it is preferred to treat NIDDM by effecting microvascular decompression of the right ventrolateral medulla oblongata, and the associated ninth and tenth cranial nerves (Cranial IX and Cranial X. respectively) using microsurgical techniques. Access to a subject's medulla and cranial nerves can be obtained by performing, for example, a retromastoid craniectomy, followed by a pericerebellar procedure which includes transection of the meninges and traversal of the cerebellum to the medulla oblongata. With the vertebral-basilar arteries thus visualized, the surgeon can perform a microvascular decompression of those pulsatile vessels which are compressing, or even grooving, the surfaces of the medulla and cranial nerves.
FIG. 1 is a basilar view of a brain 1 showing parallel views of the blood vessels at the base of the brain and the cranial nerves. Visible from this view are medulla oblongata 2, basilar artery 3, and the bifurcated vertebral artery 4. A relevant branch of basilar artery 3 is anterior inferior cerebellar artery (AICA) 5, and of vertebral artery 4 is posterior inferior cerebellar artery (PICA 6). The left portion of cerebellum 7 is shown, and the right portion is removed to show occipital lobe 8. Other visible neural structures include Cranial IX, nerve 9 and Cranial X, nerve 10. FIG. 1 shows that arteries 3-6, and their branches, are quite proximate to, if not in contact with, medulla oblongata 2. As an individual ages, and as heredity dictates, all arteries in the brain, including arteries 3-6, tend to enlarge. In some cases, such as with neurogenic NIDDM, arteries 3-6, alone or in combination, can compress the surface of the medulla oblongata 2, near the root entry of nerves 9 and 10, and may cause grooving of the medullary tissue. Because of the pulsatile nature of the blood flow through arteries 3-6, the compression tends to be pulsatile compression. It is believed that pulsatile compression of the right ventrolateral medulla oblongata 2 causes the degradation of the glucose regulatory mechanism that acts in concert with the subject's internal milieu.